August 24, 2009 (FinancialWire) — Simulations Plus, Inc.’s (NASDAQ: SLP) (Current Market Cap: $27.11 Mil.) board has approved an extension of the company’s share repurchase program through December 1.

The board originally authorized a share repurchase program enabling the buyback of up to $2.5 million in shares during a 12-month period beginning October 27, 2008. The actual buyback, however, was not initiated until December 2 of last year, according to the company.

Lancaster, California-based Simulations Plus is a developer of drug discovery and development software, which is licensed to and used in the conduct of drug research by pharmaceutical, biotechnology, and drug delivery companies.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.